IP Library Granted Patent US 7,074,760
Granted Patent B2
US 7,074,760 · App. 11/083,370 · Granted Jul 11, 2006

Polyacid glycopeptide derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,074,760
App. No.
11/083,370
Granted
Jul 11, 2006
Kind
B2
Abstract

Disclosed are derivatives of glycopeptides that are substituted at the C-terminus with a substituent that comprises two or more (e.g. 2, 3, 4, or 5) carboxy (CO 2 H) groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (15)

1. A compound of the formula:

wherein

R 17 is —CH(COOH)CH 2 COOH or —CH(COOH)CH 2 CH 2 COOH and stereoisomer thereof;

R 20 is 4-(4-chlorophenyl)benzyl or 4-(4-chlorobenzyloxy)benzyl;

or a pharmaceutically-acceptable salt.

2. The compound of claim 1 , wherein R 17 is —CH(COOH)CH 2 COOH.

3. The compound of claim 1 , wherein R 17 is —CH(COOH)CH 2 CH 2 COOH.

4. The compound of claim 1 , wherein R 20 is 4-(4-chloropbenyl)benzyl.

5. The compound of claim 1 , wherein R 20 is 4-(4-chlorobenzyloxy)benzyl.

6. A compound of the formula:

or a pharmaceutically-acceptable salt.

7. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of any one of 1 to 6 .

8. The pharmaceutical composition of claim 7 , wherein the composition further comprises a cyclodextrin.

9. The pharmaceutical composition of claim 8 , wherein the cyclodextrin is hydroxypropyl-β-cyclodextrin or sulfobutyl ether β-cyclodextrin.

10. A method of treating a bacterial disease in a mammal, the method comprising administering to the mammal a therapeutically effective amount of a compound of any one of claims 1 to 6 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033162/0891 →